MedTrace Logo

Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis

NCT00643799 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 586

Last updated 2021-02-02

No results posted yet for this study

Summary

To compare the safety and efficacy of celecoxib versus naproxen for the treatment of knee osteoarthritis

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Celecoxib

200 mg oral capsule once daily for 6 months

DRUG

Naproxen

500 mg oral capsule twice daily for 6 months

DRUG

Placebo

Matched oral placebo for 6 months

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2005-01-31
Completion
2005-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00643799 on ClinicalTrials.gov